ARES vs NDAQ

ARES exhibits strong fundamental health with a Piotroski F-Score of 7/9, indicating solid profitability and operational efficiency. However, the stock trades at a significant premium to both Graham's defensive value ($26.55) and intrinsic value ($67.56), currently priced at $155.89, reflecting high growth expectations. While revenue and earnings growth are robust—46.7% and 108.8% YoY respectively—the elevated valuation metrics (P/E of 68.07, P/B of 11.40) and bearish insider activity raise sustainability concerns. The technical trend is bearish, and the dividend payout ratio of 181% signals potential instability in income sustainability.

NDAQ presents a dichotomy between strong operational growth and bearish sentiment indicators. The Piotroski F-Score of 4/9 indicates stable but not strong financial health, while the current price of $86.37 trades at a massive premium to the Graham Number ($38.62) but remains slightly below the growth-based Intrinsic Value ($91.16). While earnings growth is exceptional (47.6% YoY) and margins are robust, the combination of a very low quick ratio (0.20), bearish insider selling by the CEO, and a 0/100 technical trend suggests significant near-term headwinds despite long-term fundamental strength.